Stockscreener 앱 받기
126.59
2.96%
3.64
시간 외 거래:
128.00
1.41
+1.11%
전일 마감가:
$122.95
열려 있는:
$121.54
하루 거래량:
1.57M
Relative Volume:
0.78
시가총액:
$19.36B
수익:
$4.34B
순이익/손실:
$850.00M
주가수익비율:
23.17
EPS:
5.4635
순현금흐름:
$921.00M
1주 성능:
+9.54%
1개월 성능:
+5.49%
6개월 성능:
+23.20%
1년 성능:
+49.00%
1일 변동 폭
$121.54
$127.41
1주일 범위
$116.10
$127.41
52주 변동 폭
$68.70
$155.53
일루미나 Stock (ILMN) Company Profile
명칭
Illumina Inc
전화
(858) 202-4500
주소
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
126.59 | 18.80B | 4.34B | 850.00M | 921.00M | 5.4635 |
|
TMO
Thermo Fisher Scientific Inc
|
470.21 | 172.63B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
190.11 | 135.42B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
579.85 | 45.95B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.75 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
299.57 | 28.94B | 3.17B | 642.63M | 516.49M | 10.77 |
일루미나 Stock (ILMN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-12 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | 재확인 | Citigroup | Neutral |
| 2025-02-28 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-02-10 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2025-02-07 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-11-12 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-10-17 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-08-28 | 업그레이드 | Argus | Hold → Buy |
| 2024-08-16 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-08-14 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-01-16 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-01-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-14 | 개시 | Stephens | Overweight |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-12-11 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-11-10 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | 개시 | Bernstein | Underperform |
| 2023-07-05 | 재개 | JP Morgan | Neutral |
| 2023-01-25 | 다운그레이드 | Argus | Buy → Hold |
| 2023-01-05 | 개시 | Scotiabank | Sector Perform |
| 2022-12-12 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-04 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-07-13 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-01-18 | 업그레이드 | Stifel | Hold → Buy |
| 2022-01-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2022-01-07 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-19 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2021-03-31 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | 개시 | Barclays | Underweight |
| 2020-12-22 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-10-13 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-09-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-09-22 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-09-21 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-09-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-08-07 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2020-08-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-24 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-04-21 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | 개시 | Wells Fargo | Underweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-10-25 | 개시 | Guggenheim | Buy |
모두보기
일루미나 주식(ILMN)의 최신 뉴스
ILMN Stock Gains Following Expanded Collaboration With Labcorp - Yahoo! Finance Canada
In Canada, researching the use of AI to accelerate answers for rare disease - Illumina
DNA Sequencing Market size to hit $108.95 Billion by 2035 | Top - openPR.com
JPMorgan Chase Boosts Illumina Stake by 17.5% - National Today
JPMorgan Chase & Co. Acquires 124,246 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina and Labcorp expand cancer testing collaboration By Investing.com - Investing.com India
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina, Labcorp Expand Collaboration to Advance Precision Oncology Testing - marketscreener.com
Illumina and Labcorp expand cancer testing collaboration - Investing.com
Synthetic Biology Market to Reach US$ 67.47 Billion by 2033 | - openPR.com
Labcorp–Illumina cancer pact targets wider access to genomic tests - Stock Titan
Investment Report: Is Illumina Inc stock a good dividend stockPortfolio Update Report & Weekly Breakout Watchlists - baoquankhu1.vn
U.S. Bioinformatics Market Is Booming Rapidly with Strong - openPR.com
Life Sciences Tools & Services Stocks Q4 Earnings: Illumina (NASDAQ:ILMN) Firing on All Cylinders - TradingView
Illumina Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Gotham Asset Management LLC Purchases 144,475 Shares of Illumina, Inc. $ILMN - MarketBeat
How Illumina’s Genomics Insurance Push And Multiomic Alliance Expansion At Illumina (ILMN) Has Changed Its Investment Story - simplywall.st
Illumina Adds Activist to Board, Names Former FDA Chief as Chair - MSN
Illumina Stock: Here’s Why Numbers Suggest a 63% Upside - TIKR.com
Illumina partners with Veritas to offer genome sequencing via insurers - Investing.com
DNA screening through health plans: Illumina’s push for preventive genomics - Stock Titan
Illumina, Inc. $ILMN Shares Sold by Ion Asset Management Ltd. - MarketBeat
Bamco Inc. NY Sells 39,378 Shares of Illumina, Inc. $ILMN - National Today
Illumina, Inc. $ILMN Stake Lessened by Cannell & Spears LLC - MarketBeat
Illumina, Inc. $ILMN Shares Sold by Casdin Capital LLC - MarketBeat
Illumina Inc. Stock (ISIN: US4523271090) Gains on Institutional Buying and Genomic Alliance Momentum - AD HOC NEWS
Illumina (ILMN) Valuation Check As Genomic Discovery Alliance Expansion Draws Fresh Investor Interest - simplywall.st
Cardiogenetic testing at scale: the TruGenome Cardiovascular Disease Test and CardioSeq Clinical Trial - Illumina
Is It Time To Reconsider Illumina (ILMN) After Prolonged Share Price Weakness? - Yahoo Finance
Spyglass Capital Management LLC Decreases Holdings in Illumina, Inc. $ILMN - MarketBeat
Quinn Opportunity Partners LLC Sells 62,423 Shares of Illumina, Inc. $ILMN - MarketBeat
Perbak Capital Partners LLP Purchases 14,315 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina Alliance Expansion With Regeneron Fuels Multiomic Data Opportunity - simplywall.st
Illumina Inc.: Why This DNA Giant Just Got Way More Interesting for You - AD HOC NEWS
Swiss National Bank Reduces Illumina Holdings - National Today
Russell Investments Group Ltd. Boosts Stake in Illumina, Inc. $ILMN - MarketBeat
Swiss National Bank Has $43.34 Million Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Schroder Investment Management Group Sells Illumina Shares - National Today
Rep. Gilbert Ray Cisneros, Jr. Buys Illumina, Inc. (NASDAQ:ILMN) Stock - MarketBeat
Schroder Investment Management Group Sells 66,235 Shares of Illumina, Inc. $ILMN - MarketBeat
First Trust Advisors LP Sells 89,600 Shares of Illumina, Inc. $ILMN - MarketBeat
Korea Investment CORP Purchases 60,500 Shares of Illumina, Inc. $ILMN - MarketBeat
ILMN SEC FilingsIllumina Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Returns Recap: Does Illumina Inc have consistent dividend growth2026 Action & Long-Term Investment Growth Plans - baoquankhu1.vn
Illumina's new connected multiomics platform set to boost its stock - MSN
Illumina partnership aims to speed rare disease diagnosis in Florida - AADC News
Illumina Stock Climbs 44.8% in a Year: What's Driving the Rally? - The Globe and Mail
Bioinformatics Market to Reach US$ 29.1 Billion by 2031 Growing - openPR.com
Capital International Inc. CA Boosts Stake in Illumina - National Today
Capital International Inc. CA Boosts Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
일루미나 (ILMN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.55%
2.50%
자본화:
|
볼륨(24시간):